Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

78,157.52

Todday's Low

77,710.01

Open at

78,152.34

Previous Close

77,502.12

Volumes

Avg Price

261.79

Historical Performance

News

15 May 26
Senores Pharmaceuticals consolidated net profit rises 77.29% in the March 2026 quarter
Net profit of Senores Pharmaceuticals rose 77.29% to Rs 31.61 crore in the quarter ended March 2026 as against Rs 17.
09 May 26
Senores Pharmaceuticals to hold board meeting
Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2026.
04 Apr 26
Senores enters into US government procurement market
Senores Pharmaceuticals, Inc. (SPI), USA, a wholly owned subsidiary of Senores Pharmaceuticals, announced that it has successfully entered into a strategic partnership by executing a formal operating agreement on 02 April 2026.
20 Jan 26
Senores Pharma slumps as Q3 PAT slides 2% QoQ to Rs 32 cr
On a consolidated basis, Senores Pharma's net profit fell 2.22% to Rs 31.66 crore in Q3 FY26 as against Rs 32.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
03-07-26 1350.00 1408.00 1332.00 1381.90 601891 35106 827710022.30 24270.85
02-07-26 1309.90 1339.80 1303.00 1336.40 207554 14946 275740498.50 24175.70
01-07-26 1343.40 1343.40 1299.00 1313.10 199323 15568 262805651.70 24005.85
30-06-26 1329.00 1335.00 1308.40 1329.90 116513 7590 154316339.50 23865.75
29-06-26 1269.20 1329.90 1267.20 1319.60 351732 19894 462260925.30 23946.25
25-06-26 1289.90 1314.10 1253.70 1269.70 429600 27657 550133476.30 24056.00
24-06-26 1278.00 1338.90 1271.00 1274.70 434980 31147 564455416.20 24021.65
23-06-26 1294.30 1330.30 1279.70 1286.60 257808 24177 336268564.60 23824.10
22-06-26 1307.00 1314.70 1285.30 1294.30 142587 11854 184562194.10 24102.90
19-06-26 1315.40 1339.90 1305.00 1315.00 185610 13906 244858089.60 24013.10

Fundamentals

Company Valuation

Market Cap (₹cr)

6356.32

PE Ratio

313.68

PB Ratio

8.48

Dividend Yield

0

ROE

0.84

ROCE

2.15

Book Value (₹)

162.832826

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 2579940 5.60 2579940 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 312689 0.68 312689 1
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2892629 6.28 2892629 3
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 6475463 14.06 6475463 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11732265 25.48 11732265 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18207728 39.54 18207728 13
Total ShareHolding for Promoter & Group 21100357 45.82 21100357 16
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1674270 3.64 1674270 26
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1363254 2.96 1363254 1
Mutual Funds / UTI 2335768 5.07 2335768 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 728829 1.58 728829 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6102121 13.25 6102121 45
plus  Non Institution
Bodies Corporate 1885404 4.09 1885404 254
Clearing Members 100112 0.22 100112 19
Directors & their Relatives 20000 0.04 20000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 409187 0.89 409187 662
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1431184 3.11 1431184 965
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7513042 16.31 7513042 69
Individuals holding nominal share capital up to Rs. 1 lakh 7056170 15.32 7056170 32053
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 532 0.00 532 1
Others 200000 0.43 200000 1
Sub Total 18851110 40.93 18851110 34065
Total Public Shareholding 24953231 54.18 24953231 34110
Total of Promoter & Public ShareHolding 46053588 100.00 46053588 34126
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 46053588 100.00 46053588 34126

Financials (₹ in cr)

Year EndMar 2025Mar 2024Mar 2023
Net Sales398.25214.5235.34
OPM (%)17.7211.6335.20
OP70.5724.9412.44
Other Income19.262.823.68
PBIDT108.9644.4116.35
INTEREST21.559.452.14
PBDT87.4134.9614.22
PBT70.5724.9412.44
EO0.000.000.00
PBT after EO70.5724.9412.44
TAXES12.23-7.774.00
PAT58.5631.468.43
EPS16.1212.216.65
Raw Material23.0114.900.98
Power and Fuel0.000.000.00
Employee Cost15.1616.5313.56
Other Manufacturing Expenses1.321.180.00
Selling and Administration Expenses8.227.9913.59
Miscellaneous Expenses0.070.090.69
Revenue (Growth %) 85.65507.07149.38
PBIDT (Growth %)145.35171.55577.75
PAT (Growth %) 86.14273.06750.96
PBIDT (Margin %)27.3620.7046.28
PAT (Margin %) 14.7014.6723.86

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 46.0530.519.828.743.80
Reserves Total 661.92137.6129.1124.955.67
Equity Share Warrants0.000.000.000.000.00
Equity Application Money0.000.000.000.000.00
Total Shareholders Funds707.97168.1238.9333.699.47
Secured Loans 52.8114.913.011.990.49
Unsecured Loans 49.9385.7857.6512.763.22
Total Debt102.74100.6960.6614.753.71
Other Liabilities1.510.651.840.050.00
Total Liabilities812.22269.46101.4348.4913.18
APPLICATION OF FUNDS :
Gross Block 61.9028.348.292.872.26
Less : Accumulated Depreciation 7.314.250.521.280.57
Less:Impairment of Assets0.000.000.000.000.00
Net Block 54.5924.097.771.591.69
Lease Adjustment0.000.000.000.000.00
Capital Work in Progress34.0118.4711.333.172.71
Producing Properties0.000.000.000.000.00
Investments 104.3881.588.2311.691.45
Current Assets, Loans & Advances
Inventories 8.664.523.122.980.34
Sundry Debtors 25.6922.0115.738.370.23
Cash and Bank Balance359.7210.450.091.411.64
Loans and Advances 18.002.988.741.225.98
Total Current Assets412.0739.9627.6813.988.19
Less : Current Liabilities and Provisions
Current Liabilities 20.1115.219.756.531.58
Provisions 1.761.190.550.140.20
Total Current Liabilities & Provisions21.8716.4010.306.671.79
Net Current Assets390.2023.5617.387.316.41
Miscellaneous Expenses not written off 0.000.000.000.000.00
Deferred Tax Assets1.050.430.180.450.77
Deferred Tax Liability0.750.220.000.000.00
Net Deferred Tax0.300.210.180.450.77
Other Assets228.74121.5556.5324.280.14
Total Assets812.22269.46101.4248.4913.18
Contingent Liabilities152.9521.630.000.130.13

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities 8.5033.8847.0886.68532.62
Investing Activities -4.37-10.05-5.23-57.07-162.94
Net Cash Flow 1.25-0.23-1.5710.35349.28
Operating Activities -2.87-24.06-43.41-19.26-20.40

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SM
Sanjay Majmudar
Chairman (Non-Executive)
Executive
Functional Directors
SJS
SWAPNIL JATINBHAI SHAH
Managing Director
MD
HNP
Hemanshu Nitinchandra Pandya
Non Executive Director
Exec.
CBS
Chetan Bipinchandra Shah
Whole Time Director & Chief Operating Officer
Dir.
DRS
Deval Rajnikant Shah
Whole Time Director & Chief Financial Officer
Dir.
AVB
Ashokkumar Vijaysinh Barot
Non Executive Director
Exec.
ADS
ARPIT DEEPAKKUMAR SHAH
Non Executive Director
Exec.
Independent Directors
JBS
Jitendra Babulal Sanghvi
Independent Director
Ind.
NBS
Naresh Bansilal Shah
Independent Director
Ind.
MDS
Manjula Devi Shroff
Independent Director
Ind.
KRG
Kalpit Rajesh Gandhi
Independent Director
Ind.
UC
Udayan Choksi
Independent Director
Ind.

Frequently Asked Questions

What is the NSE symbol and BSE code for Senores Pharmaceuticals Ltd?

Senores Pharmaceuticals Ltd trades on NSE under SENORES and on BSE under code 544319. The ISIN is INE0RB801010 and the face value is Rs 10.

What is the share price of Senores Pharmaceuticals Ltd today? +

As of 04 July 2026, Senores Pharmaceuticals Ltd trades at Rs 1,381.90, a change of 45.50 (3.40%) on the day. Prices are live and subject to change.

What is the market capitalisation of Senores Pharmaceuticals Ltd? +

As of 04 July 2026, Senores Pharmaceuticals Ltd has a market cap of about Rs 6356.32 crore. This figure is live and moves with the share price.

Is Senores Pharmaceuticals Ltd profitable? +

In March 2025, Senores Pharmaceuticals Ltd reported a profit after tax of Rs 58.56 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Senores Pharmaceuticals Ltd? +

: As of 04 July 2026, the PE (TTM) for Senores Pharmaceuticals Ltd is 313.68 and the price-to-book ratio is 8.48. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Senores Pharmaceuticals Ltd pay a dividend? +

As of 04 July 2026, the dividend yield for Senores Pharmaceuticals Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Senores Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 45.82% of Senores Pharmaceuticals Ltd. Public shareholding is 54.18%, including mutual funds at 5.07% and foreign institutional investors at 3.64%.

What were the latest annual financials of Senores Pharmaceuticals Ltd? +

In March 2025, Senores Pharmaceuticals Ltd reported net sales of Rs 398.25 crore, revenue growth of 85.65%, and earnings per share of Rs 16.12.

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web